Bionime Corporation (TPE:4737)
58.00
-1.10 (-1.86%)
Nov 20, 2026, 1:30 PM CST
| Market Cap | 4.49B +9.4% |
| Revenue (ttm) | 1.73B -9.4% |
| Net Income | -301.47M |
| EPS | -4.08 |
| Shares Out | 77.33M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 134,698 |
| Open | 57.60 |
| Previous Close | 59.10 |
| Day's Range | 57.10 - 58.90 |
| 52-Week Range | 49.75 - 72.90 |
| Beta | -0.22 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Mar 12, 2027 |